Ruthenium (II) complex cis-[Ru(II)(ŋ(2)-O(2)CC(7)H(7)O(2))(dppm)(2)]PF(6)-hmxbato induces ROS-mediated apoptosis in lung tumor cells producing selective cytotoxicity.
Ruthenium (II) complex cis-[Ru(II)(ŋ(2)-O(2)CC(7)H(7)O(2))(dppm)(2)]PF(6)-hmxbato induces ROS-mediated apoptosis in lung tumor cells producing selective cytotoxicity.
复制标题
DOI:
10.1038/s41598-020-72420-w
复制
发表时间:
2020-09-21
影响因子:
4.6
通讯作者:
Yoneyama KAG
中科院分区:
文献类型:
--
作者:
Costa MS;Gonçalves YG;Borges BC;Silva MJB;Amstalden MK;Costa TR;Antunes LMG;Rodrigues RS;Rodrigues VM;de Faria Franca E;Zoia MAP;de Araújo TG;Goulart LR;Von Poelhsitz G;Yoneyama KAG
Ruthenium complexes have been extensively explored as potential molecules for cancer treatment. Considering our previous findings on the remarkable cytotoxic activity exhibited by the ruthenium (II) complex 3-hydroxy-4-methoxybenzoate (hmxbato)-cis-[RuII(ŋ2-O2CC7H7O2)(dppm)2]PF6 against Leishmania promastigotes and also the similar metabolic characteristics between trypanosomatids and tumor cells, the present study aimed to analyze the anticancer potential of hmxbato against lung tumor cells, as well as the partial death mechanisms involved. Hmxbato demonstrated selective cytotoxicity against A549 lung tumor cells. In addition, this complex at a concentration of 3.8 µM was able to expressively increase the generation of reactive oxygen species (ROS) in tumor cells, causing an oxidative stress that may culminate in: (1) reduction in cellular proliferation; (2) changes in cell morphology and organization patterns of the actin cytoskeleton; (3) cell arrest in the G2/M phase of the cell cycle; (4) apoptosis; (5) changes in the mitochondrial membrane potential and (6) initial DNA damage. Furthermore, we demonstrated that the induction of programmed cell death can occur by the intrinsic apoptotic pathway through the activation of caspases. It is also worth highlighting that hmxbato exhibited predominant actions on A549 tumor cells in comparison to BEAS-2B normal bronchial epithelium cells, which makes this complex an interesting candidate for the design of new drugs against lung cancer.
登录
查看更多内容
DOI:
10.1186/1478-811x-8-31
发表时间:
2010-12-22
期刊:
Cell communication and signaling : CCS
影响因子:
--
作者:
Chaitanya GV;Steven AJ;Babu PP
通讯作者:
Babu PP
影响因子:
3.9
作者:
Chen, Jin-can;Zhang, Yao;Chen, Lan-mei
通讯作者:
Chen, Lan-mei
影响因子:
5.1
作者:
De Grandis, Rone Aparecido;da Silva dos Santos, Patrick Wellington;Pavan, Fernando Rogerio
通讯作者:
Pavan, Fernando Rogerio
影响因子:
7.3
作者:
Caruso, Francesco;Rossi, Miriam;Pettinari, Claudio
通讯作者:
Pettinari, Claudio
影响因子:
3.9
作者:
Costa, Monica S.;Goncalves, Yasmim G.;Yoneyama, Kelly A. G.
通讯作者:
Yoneyama, Kelly A. G.